Your browser doesn't support javascript.
loading
Randomized trial of cyclophosphamide, methotrexate, and fluorouracil chemotherapy added to tamoxifen as adjuvant therapy in postmenopausal women with node-positive estrogen and/or progesterone receptor-positive breast cancer: a report of the National Cancer Institute of Canada Clinical Trials Group. Breast Cancer Site Group.
Pritchard, K I; Paterson, A H; Fine, S; Paul, N A; Zee, B; Shepherd, L E; Abu-Zahra, H; Ragaz, J; Knowling, M; Levine, M N; Verma, S; Perrault, D; Walde, P L; Bramwell, V H; Poljicak, M; Boyd, N; Warr, D; Norris, B D; Bowman, D; Armitage, G R; Weizel, H; Buckman, R A.
  • Pritchard KI; Toronto-Sunnybrook Regional Cancer Centre, University of Toronto, Ontario, Canada. kathy_pritchard@octrf.on.ca
J Clin Oncol ; 15(6): 2302-11, 1997 Jun.
Article en En | MEDLINE | ID: mdl-9196144
Asunto(s)
Search on Google
Imprimir
XML
PubMed Links

Banco de datos: MEDLINE Asunto principal: Tamoxifeno / Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Clinical_trials Límite: Female / Humans / Middle aged Idioma: En Año: 1997 Tipo del documento: Article
Search on Google
Imprimir
XML
PubMed Links

Banco de datos: MEDLINE Asunto principal: Tamoxifeno / Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Clinical_trials Límite: Female / Humans / Middle aged Idioma: En Año: 1997 Tipo del documento: Article